JP5250168B2 - 乳癌において差次的に発現される遺伝子 - Google Patents

乳癌において差次的に発現される遺伝子 Download PDF

Info

Publication number
JP5250168B2
JP5250168B2 JP2001551099A JP2001551099A JP5250168B2 JP 5250168 B2 JP5250168 B2 JP 5250168B2 JP 2001551099 A JP2001551099 A JP 2001551099A JP 2001551099 A JP2001551099 A JP 2001551099A JP 5250168 B2 JP5250168 B2 JP 5250168B2
Authority
JP
Japan
Prior art keywords
seq
polypeptide
protein
amino acid
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2001551099A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003519480A5 (https=
JP2003519480A (ja
Inventor
イエルク カウフマン，
グレッグ ハーロウ，
クリストフ レインハード，
サンマオ カング，
Original Assignee
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド filed Critical ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド
Publication of JP2003519480A publication Critical patent/JP2003519480A/ja
Publication of JP2003519480A5 publication Critical patent/JP2003519480A5/ja
Application granted granted Critical
Publication of JP5250168B2 publication Critical patent/JP5250168B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2001551099A 2000-01-10 2001-01-09 乳癌において差次的に発現される遺伝子 Expired - Fee Related JP5250168B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17546200P 2000-01-10 2000-01-10
US60/175,462 2000-01-10
PCT/US2001/000899 WO2001051515A2 (en) 2000-01-10 2001-01-09 Genes differentially expressed in breast cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012071880A Division JP2012143242A (ja) 2000-01-10 2012-03-27 乳癌において差次的に発現される遺伝子

Publications (3)

Publication Number Publication Date
JP2003519480A JP2003519480A (ja) 2003-06-24
JP2003519480A5 JP2003519480A5 (https=) 2006-01-05
JP5250168B2 true JP5250168B2 (ja) 2013-07-31

Family

ID=22640304

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001551099A Expired - Fee Related JP5250168B2 (ja) 2000-01-10 2001-01-09 乳癌において差次的に発現される遺伝子
JP2012071880A Withdrawn JP2012143242A (ja) 2000-01-10 2012-03-27 乳癌において差次的に発現される遺伝子

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012071880A Withdrawn JP2012143242A (ja) 2000-01-10 2012-03-27 乳癌において差次的に発現される遺伝子

Country Status (9)

Country Link
US (1) US7605246B2 (https=)
EP (2) EP1985701B1 (https=)
JP (2) JP5250168B2 (https=)
AT (1) ATE402258T1 (https=)
AU (1) AU2001229367A1 (https=)
DE (1) DE60134956D1 (https=)
ES (2) ES2386317T3 (https=)
PT (1) PT1248841E (https=)
WO (1) WO2001051515A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7081517B2 (en) * 2000-01-10 2006-07-25 Chiron Corporation Genes differentially expressed in breast cancer
DE102011110592A1 (de) 2011-08-18 2013-02-21 Rena Gmbh Verfahren zum Konditionieren von flachen Gegenständen
CN112837822B (zh) * 2020-09-24 2023-05-02 广州市疾病预防控制中心(广州市卫生检验中心、广州市食品安全风险监测与评估中心、广州医科大学公共卫生研究院) 预测covid-19患者发生轻至重度进展的标志物及试剂盒和建立方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
US4551433A (en) 1981-05-18 1985-11-05 Genentech, Inc. Microbial hybrid promoters
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
EP0127839B1 (en) 1983-05-27 1992-07-15 THE TEXAS A&M UNIVERSITY SYSTEM Method for producing a recombinant baculovirus expression vector
US4745051A (en) 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
ZA848495B (en) 1984-01-31 1985-09-25 Idaho Res Found Production of polypeptides in insect cells
US4837148A (en) 1984-10-30 1989-06-06 Phillips Petroleum Company Autonomous replication sequences for yeast strains of the genus pichia
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
IL77186A0 (en) 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
US4929555A (en) 1987-10-19 1990-05-29 Phillips Petroleum Company Pichia transformation
ATE135397T1 (de) 1988-09-23 1996-03-15 Cetus Oncology Corp Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
FR2649120B1 (fr) 1989-06-30 1994-01-28 Cayla Nouvelle souche et ses mutants de champignons filamenteux, procede de production de proteines recombinantes a l'aide de ladite souche et souches et proteines obtenues selon ce procede
WO1991016116A1 (en) 1990-04-23 1991-10-31 Cellpro Incorporated Immunoselection device and method
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
CA2121038C (en) 1992-08-13 2002-05-14 Akiya Yamada Oral preparation for release in lower digestive tracts
AU3395900A (en) 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
CA2388922A1 (en) * 1999-11-19 2001-05-25 Human Genome Sciences, Inc. 23 human secreted proteins

Also Published As

Publication number Publication date
ATE402258T1 (de) 2008-08-15
US7605246B2 (en) 2009-10-20
DE60134956D1 (de) 2008-09-04
ES2311016T3 (es) 2009-02-01
PT1248841E (pt) 2008-09-15
EP1248841B1 (en) 2008-07-23
US20020004239A1 (en) 2002-01-10
WO2001051515A2 (en) 2001-07-19
JP2012143242A (ja) 2012-08-02
WO2001051515A3 (en) 2002-01-24
EP1248841A2 (en) 2002-10-16
ES2386317T3 (es) 2012-08-17
JP2003519480A (ja) 2003-06-24
EP1985701A2 (en) 2008-10-29
AU2001229367A1 (en) 2001-07-24
EP1985701B1 (en) 2012-05-30
EP1985701A3 (en) 2009-01-07
HK1118861A1 (en) 2009-02-20

Similar Documents

Publication Publication Date Title
US6703221B1 (en) Notch receptor ligands and uses thereof
AU700915B2 (en) Lung cancer marker
JP6957546B2 (ja) ヒト非小細胞肺癌における転座及び変異体ｒｏｓキナーゼ
KR20090111307A (ko) 전립선 특이적 전사물 및 전립선암의 치료 및 진단에 사용되는 이의 용도
JP2012143242A (ja) 乳癌において差次的に発現される遺伝子
WO2001012664A2 (en) Notch receptor ligands and uses thereof
US20130196314A1 (en) Genes Differentially Expressed in Breast Cancer
JP2003519480A5 (https=)
US20040161775A1 (en) Gene SHINC-1 and diagnostic and therapeutic uses thereof
US20020061552A1 (en) Mammalian dishevelled-associated proteins
HK1118861B (en) Genes differentially expressed in breast cancer
US20030186232A1 (en) Human and non-human primate homologues of Nkd protein, nucleic acid sequences encoding, and uses thereof
US20020146712A1 (en) Tumor suppressor
CA2245340A1 (en) Traf4-associating protein

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20041214

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20041214

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20041214

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050516

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071116

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101004

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20101228

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110111

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110202

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111129

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120224

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120302

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120327

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121226

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130304

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130327

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130415

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160419

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees